CN1060656C - Yuganwan pill-medicine for hepatitis - Google Patents

Yuganwan pill-medicine for hepatitis Download PDF

Info

Publication number
CN1060656C
CN1060656C CN95110516A CN95110516A CN1060656C CN 1060656 C CN1060656 C CN 1060656C CN 95110516 A CN95110516 A CN 95110516A CN 95110516 A CN95110516 A CN 95110516A CN 1060656 C CN1060656 C CN 1060656C
Authority
CN
China
Prior art keywords
hepatitis
medicine
pill
yuganwan
examples
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN95110516A
Other languages
Chinese (zh)
Other versions
CN1128157A (en
Inventor
郝玉生
郝继高
郝继尚
郝继品
郝爱英
郝素云
于明伟
孟龙青
阎东新
Original Assignee
郝玉生
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 郝玉生 filed Critical 郝玉生
Priority to CN95110516A priority Critical patent/CN1060656C/en
Publication of CN1128157A publication Critical patent/CN1128157A/en
Application granted granted Critical
Publication of CN1060656C publication Critical patent/CN1060656C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to a pill medicine-Yuganwan for treating various kinds of acute hepatitis, chronic hepatitis and hepatitis concurrent with cirrhotic ascites. The pill medicine is mainly prepared by grinding traditional Chinese medicines with the functions of clearing heat and toxic materials, promoting blood generation, removing dampness by diuresis and removing jaundice into fine powder and making the fine powder into pills. The pill medicine is characterized in that for treating acute hepatitis and chronic hepatitis, the raw materials comprise 20 to 60% of raw barley sprout, 10 to 40% of black alum and 5 to 25% of artemisia capillaris or rice bean; for treating hepatitis concurrent with cirrhotic ascites, 5 to 25% of polyporus or tuckahoe or water plantain or talcum is added to the raw materials. The pill medicine has the advantages of high cure rate, high radical treatment, no toxic or side effect, short treatment period, low medicine expense and great popularization value.

Description

Yuganwan-medicinal pill for hepatitis
The invention belongs to a kind of Chinese medicine pill for the treatment of various acute, chronic hepatitis and treatment hepatitis concurrent cirrhotic ascites.Simultaneously, dull yellowish colored skin, anemia also there is curative effect preferably.
Various hepatitis is a kind of commonly encountered diseases, frequently-occurring disease, and medicine is also a lot of, as glucuronolatone, interferon, polyinosini, liver must answer, MIEAOLING, hepatoprotective ball or the like.These medicines have the different curative effect of degree to control acute hepatitis and treatment chronic hepatitis.But the one, cure rate is low, radical-ability is poor; The 2nd, the drug value height, and treatment time is long, for the patient brings heavy financial burden.Particularly at treatment hepatitis concurrent cirrhosis ascites disease, effect is more undesirable.In recent years, China's performance Chinese medicine advantage, research and development are released many Chinese patent medicines and are used for the treatment of various hepatitis.As the compound recipe Liver Nourishing Pill that White Cloud Mountain, Tonghua, Jilin Province pharmaceutical factory produces, it is made up of 28 flavor Chinese medicines such as Radix Gentianae, Herba Taraxaci, Herba Sedi, Radix Salviae Miltiorrhizae, Radix Bupleuri, Radix Et Rhizoma Rhei.Cure mainly hepatitis B.This factory also produces a kind of strong liver regeneration ball, and its main component has Chinese medicines such as Fructus Amomi, Rhizoma Cyperi, Fructus Tsaoko, Cortex Cinnamomi, radix curcumae, Rhizoma Corydalis to make.Though these two kinds of new drugs have raising on curative effect, cure rate is still unsatisfactory, and continuously medicine time long, flavour of a drug are many, the medicine valency is still than higher; And have the anemia of pregnant woman to prohibit clothes, many limitation such as fasting raw food, maror during the medication, even also have side effect such as loose stool, nauseating, weak, stupor.
The objective of the invention is to overcome the deficiency that above-mentioned Chinese and western drugs is treated various hepatitis and cirrhosis ascites disease, a kind of curative effect height, strong, the very economical again Chinese medicine pill-Yuganwan-medicinal pill for hepatitis of short treating period of radical-ability are provided.
The present invention is realized by following technical scheme, treat the Yuganwan-medicinal pill for hepatitis of various acute, chronic hepatitis, it is ground into the smalls pill and is formed by heat-clearing and toxic substances removing hemopoietic class, the drug matching of removing dampness and eliminating jaundice class, it is characterized in that its prescription and component content thereof are: select heat-clearing and toxic substances removing hemopoietic class Chinese medicine Fructus Hordei Germinatus, Alumen preparata two flavors for use, consumption is respectively 20~60%, and 10~40%; Select removing dampness and eliminating jaundice class Chinese medicine for use, Herba Artemisiae Scopariae or Semen Phaseoli 5~25%.Be used for the treatment of the Yuganwan-medicinal pill for hepatitis of hepatitis concurrent cirrhosis ascites disease, it is characterized in that,, add diuretic eliminating dampness by diuresis class Chinese medicine Polyporus or Poria or Rhizoma Alismatis or Talcum 5~25% again, be ground into the smalls pill and form as above-mentioned feature.
Heat-clearing and detoxifying herb Fructus Hordei Germinatus and Alumen preparata that the present invention selects for use, broken the similar medicine that the various hepatitis of traditional treatment is selected for use, this two flavors medicine not only has antipyretic and antidote functions, also have hemopoietic dampness removing, the digestant effect of strengthening the spleen and stomach, played antiviral, fall enzyme reason irritability, eliminated pain in the hepatic region and merit tired, anorexia.Used removing dampness and eliminating jaundice class Chinese medicine Herba Artemisiae Scopariae or Semen Phaseoli, can dampness removing jaundice eliminating, disperse the hot and suffocating outer fur that reaches, in let out damp and hot and swing turbid cause new.Play clearing heat secreting bile, the heat of going to become silted up, clear carbuncle stagnate, the function of regulating QI machine.The used Yuganwan-medicinal pill for hepatitis of cirrhotic ascites adds promoting diuresis to eliminate damp pathogen class Chinese medicine Polyporus or other three each of distinguishing the flavor of selected for use and mainly plays elimination ascites, protects the liver the effect of dampness removing.Because the said medicine that the present invention selects for use, not only noted heat-clearing and toxic substances removing, promptly kill patient's hepatitis virus, the more important thing is and noted overcoming the imbalance of each systemic-function of patient's human body internal organs and the disorder of liver and gall taste mechanism of qi, to strengthen the resistivity of patient's human body, hepatitis symptom and index are alleviated rapidly, remarkable to liver cirrhosis, hepatic ascites, jaundice therapeutic effect simultaneously.Because of antibody forms rapidly, and can strengthen the function of liver and gall taste, the combination that takes stopgap measures and effect a permanent cure is so Yuganwan-medicinal pill for hepatitis of the present invention has cure rate height, efficacy consolidation, is difficult for recurrence, radical-ability is strong, short treating period, instant effect, negative conversion rate advantages of higher.It has the blood circulation of improvement, the effect of hemopoietic dampness removing simultaneously, so dull yellowish colored skin, basin mass formed by blood stasis are also had higher curative effect.And because used Chinese medicine is general Chinese herbal medicine, price is low, and flavour of a drug are few, so use its very economical.For the acute hepatitis patient, can cure a general course of treatment (30~40 days), and required expenses for medicine only picks up surplus yuan.The general 2-3 of a chronic hepatitis patient course of treatment (60-90 days) can cure, and required expenses for medicine only is several ten yuan, promptly is that cirrhotic ascites its expenses for medicine general ten courses of treatment is also only used over one hundred unit.As seen value is low.This Yuganwan-medicinal pill for hepatitis is without any side effects in addition, and is also harmless with the medicine adapted of any other treating the liver inflammation.
The embodiment of the invention:
Treat the Yuganwan-medicinal pill for hepatitis prescription and the usage and dosage of various acute, chronic hepatitis: Fructus Hordei Germinatus 800 gram, Alumen preparata 150 grams, Herba Artemisiae Scopariae 150 grams are ground into smalls water and beat and be every gram one ball.One after each meal, every day three times, each 1-6 ball (gram).Dull yellowish colored skin, anemia are the same.
The Yuganwan-medicinal pill for hepatitis prescription and the usage and dosage of treatment cirrhotic ascites: Fructus Hordei Germinatus 800 gram, Alumen preparata 150 grams, Herba Artemisiae Scopariae 150 grams, Polyporus 250 grams are ground into smalls water and beat and be ball, taking medicine after meal every day three times, each 3-6 gram.
Various acute, chronic hepatitis 441 examples that my trial edition Yuganwan-medicinal pill for hepatitis treatment is once made a definite diagnosis.Acute hepatitis 256 examples wherein, acute icterohepatitisshock 124 examples in the middle of this, wherein male 74 examples, women 50 examples, 24 examples in 4-7 year, 32 examples in 8-15 year, 68 examples in 16-55 year.Acute no icterohepatitis 132 examples, wherein male 80 examples, women 52 examples.36 examples in 15-30 year, 96 examples in 31-55 year.Through a treatment in month, cure 225 examples in two kinds of acute hepatitises, account for 88%; Produce effects 12 examples account for 4.7%.9 examples that take a turn for the better account for 3.4%; Change doctor's 10 examples midway, account for 3.9%.In chronic hepatitis 185 examples of accepting for medical treatment, wherein male 108 examples, women 77 examples; 75 examples in 15-30 year, 110 examples in 31-55 year through treatment in 3 months, are cured 150 examples, account for 81%, and produce effects 16 examples account for 8.7%; 5 examples that take a turn for the better account for 2.7%; Change doctor's 14 examples midway, account for 7.6%.
My Yuganwan-medicinal pill for hepatitis on probation tries treating the liver sclerosis ascites 300 examples, wherein male 230 examples, women 70 examples; 30 people in 20-40 year account for 10%; 220 people in 40-62 year account for 73%; 50 people in 63-69 year account for 17%.Through treatment in ten months, wherein cure 120 people, account for 40%; Produce effects 87 people account for 21%; 30 people that take a turn for the better account for 10%, and invalid 63 people account for 21%.
More than should say so other people of the therapeutic effect of two kinds of Yuganwan-medicinal pill for hepatitis on probation satisfied, wherein 20 routine model cases are seen attached list.20 examples Yuganwan-medicinal pill for hepatitis curative effect table on probation<be the laboratory examination index, symptom and sign is slightly 〉
Figure 9511051600071
Figure 9511051600081

Claims (1)

1, a kind of Yuganwan-medicinal pill for hepatitis for the treatment of various acute, chronic hepatitis is characterized in that the medicament of being made by the composition of following consumption: Fructus Hordei Germinatus 800 gram Alumen preparata 150 gram Herba Artemisiae Scopariaes 150 grams.
CN95110516A 1995-06-29 1995-06-29 Yuganwan pill-medicine for hepatitis Expired - Fee Related CN1060656C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN95110516A CN1060656C (en) 1995-06-29 1995-06-29 Yuganwan pill-medicine for hepatitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN95110516A CN1060656C (en) 1995-06-29 1995-06-29 Yuganwan pill-medicine for hepatitis

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN00107173A Division CN1094355C (en) 2000-05-01 2000-05-01 Yugan pill for curing hepatitis and ascites due to cirrhosis

Publications (2)

Publication Number Publication Date
CN1128157A CN1128157A (en) 1996-08-07
CN1060656C true CN1060656C (en) 2001-01-17

Family

ID=5077892

Family Applications (1)

Application Number Title Priority Date Filing Date
CN95110516A Expired - Fee Related CN1060656C (en) 1995-06-29 1995-06-29 Yuganwan pill-medicine for hepatitis

Country Status (1)

Country Link
CN (1) CN1060656C (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1032295A (en) * 1988-02-22 1989-04-12 黑龙江省中医学院中药厂 The grand manufacture method of sharp liver
CN1071581A (en) * 1991-10-19 1993-05-05 孙明君 The compound method of Antiheptitic " Ganyanling "

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1032295A (en) * 1988-02-22 1989-04-12 黑龙江省中医学院中药厂 The grand manufacture method of sharp liver
CN1071581A (en) * 1991-10-19 1993-05-05 孙明君 The compound method of Antiheptitic " Ganyanling "

Also Published As

Publication number Publication date
CN1128157A (en) 1996-08-07

Similar Documents

Publication Publication Date Title
CN101797326B (en) Chinese materia medica preparation for treating borborygmus diarrhoea and preparation method thereof
CN1194843A (en) Method for producing green health medicine
CN103417904B (en) Traditional Chinese medicine composition for treating chronic cheilitis and preparing method thereof
CN1328834A (en) Capsule for curing cholecystitis
CN101422579B (en) Traditional Chinese medicine preparation for treating oral ulcer
CN102512632B (en) Chinese herbal composition for treating abnormal menstruation
CN1332702C (en) Medicine for treating psoriasis
CN1054528C (en) Already prepared traditional Chinese medicine for treating psoriasis named "kangyinlin"
CN102988616A (en) Chinese medicinal composition for treating anemia
CN1082376C (en) Pathogenic factor eliminating and healthy energy supporting anticancer medicine
CN1056064C (en) Medicine for curing liver cancer and its making method
CN102133167A (en) Freckle removing facial mask made of traditional Chinese medicine and preparation process thereof
CN1557354A (en) Chinese medicine aqueous pill preparation for treating hepatitis B and its preparation process
CN1237443A (en) Medicine for curing rheumatic heart disease
CN104258359A (en) Traditional Chinese medicine combination for curing pregnancy reaction and preparation method of preparations thereof
CN104873911B (en) A kind of pyemic traditional Chinese medicine for oral administration of auxiliary treatment
CN1060656C (en) Yuganwan pill-medicine for hepatitis
CN1094355C (en) Yugan pill for curing hepatitis and ascites due to cirrhosis
CN105362682A (en) External-use medicine for treating hypomenorrhea
CN1422628A (en) Baixue-Genzhi-Changshoubao-Chinese medicine for treating leukemia and concurrently treating aplastic anemia
CN1044198C (en) Prescription of weifuyuan capsule and its preparation method
CN1333026A (en) Medicine for treating hyperplasia of mammary glands
CN1145229A (en) Method for production of cleaning powder for treating internal organs of the body
CN1052606A (en) A kind of preparation method of curing the pharmaceutical preparation of dysmenorrhea
CN1123355C (en) Process for preparing Chinese medicine preparation of treating pyelonephritis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee